The purpose of the present invention is to provide a novel therapeutic agent or a novel prophylactic agent for diseases associated with abnormal glucose metabolism. The present invention is a therapeutic agent or a prophylactic agent for diseases associated with abnormal glucose metabolism, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
申请公布号
EP2808018(A4)
申请公布日期
2015.07.15
申请号
EP20130740913
申请日期
2013.01.25
申请人
TEIJIN PHARMA LIMITED;NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY